June 2, 2022
Led by Michelle Floris-Moore, MD, and Joe Eron, MD, this effort at UNC is one 11 infectious diseases divisions across the country selected for this pilot program launched by the Infectious Diseases Society of America with the CDC.
May 17, 2022
Melissa Miller, PhD, director of the Clinical Molecular Microbiology Laboratory at UNC Medical Center, talks with the News and Observer about why an at-home COVID test might give false-negative results and tips on how to determine if follow-up testing is needed.
May 16, 2022
A study published in The Lancet Digital Health led by UNC School of Medicine’s Emily R. Pfaff, PhD, shows how the National COVID Cohort Collaborative used XGBoost machine learning models to better define long COVID and identify potential long COVID patients with a high degree of accuracy.
April 19, 2022
This virtual seminar series will provide a background in the use of machine learning tools to answer clinical questions, understand the strengths and limitations of these methods, and examine real-world examples of machine learning methodology in clinical research. The series is co-sponsored by the UNC Core Center for Clinical Research and the UNC Program for Precision Medicine in Health Care.
March 30, 2022
UNC-Chapel Hill scientists led by Camille Ehre, PhD, show how cells packed with SARS-CoV-2 detach from the upper airway and spread deep into lungs where severe COVID can take root. They also discovered how an asthmatic reaction to allergens battles the virus to hold severe COVID at bay.
March 22, 2022
A UNC Maternal-Fetal Medicine Network trial has shown that, among pregnant and postpartum individuals, SARS-CoV-2 infection was associated with increased risk of maternal mortality or serious morbidity from obstetric complications.
March 21, 2022
Super Steward Awards recognize colleagues’ meaningful contributions to support the appropriate and effective use of antimicrobials at UNC Medical Center.
February 24, 2022
The compound CMX521 significantly reduced lung viral titer and symptoms in a SARS-CoV-2 mouse model, as reported by biomedical company Chimerix in collaboration with the Rapidly Emerging Antiviral Drug Development Initiative at UNC-Chapel Hill. UNC School of Medicine faculty Nat Moorman, PhD, and Mark Heise, PhD, are key researchers in this program.
February 8, 2022
The COVID-19 pandemic has demonstrated a critical need to establish a pre-emptive stockpile of tangible immunobiological countermeasures to accelerate the response to potential pandemic threats. To address this need we have established a pandemic response repository through microbial and immunological surveillance and epidemiology (PREMISE) initiative.
January 26, 2022
Current therapeutic options and resources to aid appropriate selection.
January 26, 2022
Join the UNC Program for Precision Medicine in Health Care (PPMH) for Precision Medicine Approaches to Addressing COVID-19, a free virtual mini-symposium from 1:00-3:00pm on Wednesday February 23, 2022. Presenters will explore how data has informed our response to the COVID-19 pandemic: the collection, analysis, and interpretation of COVID-related data.
December 15, 2021
The Eshelman Institute for Innovation recently opened its pre-proposal application for the 2022 annual grant cycle. The Institute seeks to fund translational research related to therapeutics focused on oncology, infectious disease, and neuroscience, including rare diseases, and all digital health technologies. The Institute also welcomes ideas for devices and diagnostics, and other therapeutic areas and services.